Max Reinsurance (NASDAQ:MXRE)
Historical Stock Chart
From Feb 2020 to Feb 2025
![Click Here for more Max Reinsurance Charts. Click Here for more Max Reinsurance Charts.](/p.php?pid=staticchart&s=N%5EMXRE&p=8&t=15)
Max Re Capital Ltd. (NASDAQ: MXRE; BSX: MXRE BH) today announced plans
to establish a U.S.-based excess and surplus lines platform that will
complement the company’s existing insurance
and reinsurance operations based in Bermuda and Dublin, Ireland. The
proposed new subsidiary, which Max Re Capital intends to launch in the
first quarter of 2007, will be named Max Specialty Insurance Company (“Max
Specialty”) and will be based in Richmond,
Virginia, with regional offices in Atlanta, San Francisco and
Philadelphia.
Joining Max Specialty as its President and Chief Executive Officer will
be Stephen J. Vaccaro, Jr., a thirty-year insurance industry veteran
best known for his leadership role in the dramatic growth and
performance of the Essex Insurance Company, an affiliate of the Markel
Corporation, from 1993 to 2004. During his tenure there, Mr. Vaccaro
helped grow Essex revenues five-fold, from $100 million to more than
$500 million, achieving a nine-year combined ratio of less than 80%
while significantly expanding the company’s
product base.
W. Marston Becker, Chairman and Chief Executive Officer of Max Re
Capital, said: “We look forward to the launch
of Max Specialty, which will add a significant new distribution channel
and base of potential clients to Max Re Capital’s
global insurance and reinsurance businesses, and enable us to provide a
broader range of insurance products and services to customers in the
United States and around the world.
“We are particularly delighted to welcome
Steve Vaccaro and his talented team of underwriting professionals to our
organization. Steve has a proven ability to lead insurance operations
and consistently deliver underwriting profits in both soft and hard
market conditions. Having Steve and his team aboard will allow us to tap
into the excess and surplus segment of the insurance business, which has
been the industry’s fastest-growing segment
for two decades. It will also enhance our ability to generate
underwriting profits and to produce a growing and diversified book of
business. Most importantly, Steve and his team will enable us to provide
a more complete range of solutions for our existing and prospective
insurance clients, building our value to them and, in turn, for our
shareholders,” Mr. Becker said.
Mr. Vaccaro said: “I am pleased to be joining
the Max Re Capital organization and look forward to working with them
and my team of underwriting professionals to launch Max Specialty as a
first-class excess and surplus lines insurance company early next year.”
Max Specialty is expected to operate across two divisions, Brokerage and
Managing General Agency (“MGA”).
Brokerage, to be headed by Jonathan Hahn, and MGA, to be headed by Bryan
Sanders, will both offer property, inland marine, casualty, excess
liability, and umbrella insurance products.
Mr. Hahn has more than fifteen years of insurance industry experience;
since 1995, he has been associated with the Markel Corporation, where he
was responsible for the profitable growth of a significant excess
property book. Mr. Sanders has more than twenty-five years of experience
in excess and surplus lines insurance, and particularly in building and
developing a national wholesale operation.
Located in Hamilton, Bermuda, Max Re Capital Ltd., through its principal
operating subsidiaries, Max Re Ltd., Max Insurance Europe Limited and
Max Re Europe Limited, offers insurance and reinsurance solutions to
property and casualty insurers, life and health insurers and large
corporations.
This release includes statements about future expectations, plans and
prospects of the Company which constitute forward-looking statements for
purposes of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those suggested by such statements,
including the risk that the SEC’s view of the
conclusions reached by the Audit and Risk Management Committee of our
Board of Directors in connection with the internal review of three
finite risk retrocessional contracts written in 2001 and 2003, which
caused the Company to restate its audited financial statements for the
years ended December 31, 2005, 2004, 2003, 2002 and 2001 and unaudited
financial statements for the periods ended March 31, 2006 and June 30,
2006, may differ, perhaps materially, and result in material changes to
information contained in the Company’s past
SEC filings, including financial statements and financial information.
For further information regarding cautionary statements and factors
affecting future results, please refer to the Company’s
Annual Report on Form 10-K/A (Amendment No. 2) for the year ended
December 31, 2005 and other documents filed by the Company with the SEC.
The Company undertakes no obligation to publicly update or revise any
forward-looking statement whether as a result of new information, future
developments or otherwise.